CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

Deep Dive - Clinical Laboratory Services Europe

Selecting Post-Mortem Toxicology Testing that Can Stand Up to Uncertainty

By

Life Sciences Review | Tuesday, August 11, 2026

An unexplained death investigation often starts with very little to go on. There may be no clear medical cause, limited information from the scene, no reliable witness account and no obvious physical explanation. That can leave the coroner or pathologist with a difficult question: did a substance play a role, or can toxicology help rule it out? Choosing a laboratory service therefore involves more than selecting a testing panel. The service needs to work effectively when important details are missing, without allowing that uncertainty to result in delays or inconclusive interpretation.


Drug-related deaths are also becoming more difficult to investigate. Routine screening remains important, but post-mortem testing increasingly has to deal with unfamiliar compounds, very low concentrations, prescription histories and combinations that fall outside established testing assumptions. Novel psychoactive substances make this particularly challenging because some can be highly potent at concentrations that are difficult to detect. Laboratories need broad screening capability and sufficiently sensitive detection methods, along with the expertise to recognize unusual chemistry and identify when targeted testing is necessary. Without that combination, a report may be technically accurate but still fail to answer the main question behind the investigation.


“Toxicology UK brings post-mortem toxicology testing and interpretation together within the same service model.”


Turnaround time has consequences well beyond laboratory administration. Delays can postpone an inquest, extend uncertainty for families, complicate police decisions and slow the identification of emerging public health patterns that might otherwise be preventable. Speed alone, however, is not enough. Reporting that a substance is present without explaining what the finding means can leave the pathologist with another question to resolve. When assessing a provider, buyers should look at testing capacity alongside the scientific expertise available to interpret the results. A toxicology report is most useful when it arrives in time to narrow the possible explanations for a death.


Accreditation provides an essential foundation, but it does not tell the whole story. ISO credentials and established quality systems matter because toxicology evidence may face scrutiny long after the original analysis. What matters in practice is how those standards are applied through internal controls, external quality schemes, method validation and corrective action processes. Reporting requires the same care. The final report needs enough scientific reasoning to withstand expert review while explaining the findings in terms that coroners can use and understand outside the laboratory.


Interpretation is often the more difficult part of the work. Detecting and measuring a substance does not, by itself, establish its significance. The concentration has to be considered alongside the case history, possible tolerance, pathology findings and any other substances present. Post-mortem redistribution and gaps in the available background information can make that judgment more complicated. Adding more detail to a report does not necessarily make the answer clearer. What decision-makers need is a provider that can explain the significance of each finding without losing the uncertainty and context surrounding it, rather than leaving them to draw conclusions from concentration values alone.


“Accredited analytical work is provided through NMS Labs, while UK-based toxicologists support case strategy, reporting, interpretation and HM Coroner inquests.”


Toxicology UK brings post-mortem toxicology testing and interpretation together within the same service model. Accredited analytical work is provided through NMS Labs, while UK-based toxicologists support case strategy, reporting, interpretation and HM Coroner inquests. This approach is suited to investigations where broad screening may need to be followed by targeted testing before the findings can be clearly explained. Its Toxicological Significance Score gives coroners a structured way to assess the likely relevance of each drug finding. The result is a service designed to provide more than an analytical result, giving coroners information they can use to understand what the toxicology findings mean within the context of the case.


Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/deep-dive/selecting-postmortem-toxicology-testing-that-can-stand-up-to-uncertainty-nwid-3632.html